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Additional Materials and Methods 
Strains, Media, and Growth Conditions 
Caldicellulosiruptor bescii and Escherichia coli strains used in this study are listed in Table 
S1. All C. bescii strains were grown anaerobically at 65°C on solid or in liquid low osmolarity 
defined (LOD) medium (1), as previously described, with .5 % w/v D(+)-Cellobiose (Acros 
Organics, NJ, U.S.A., Code: 108465000, Lot: A0384025) as the sole carbon source, final pH 6.8, for 
routine growth and transformation experiments (2). For growth of uracil auxotrophic strains 
based off of JWCB029 (ΔpyrFA ldh::ISCbe4 Δcbe1 ΔcelA), the LOD medium contained 40 µM 
uracil. This concentration of uracil does not support growth of C. bescii as sole carbon source. E. 
coli strain DH5α was used for plasmid DNA construction and preparation using standard 
techniques as described (3). E. coli cells were cultured in LB broth supplemented with apramycin 
(50 μg/mL) and plasmid DNA was isolated using a Qiagen Mini-prep kit (Qiagen, Hilden, 
Germany). Chromosomal DNA from Caldicellulosiruptor strains was extracted using the Quick-
gDNA™ MiniPrep (Zymo Research, Irvine, CA, U.S.A.) as previously described (4). 
Construction and Transformation of CelA and CelA Derivative Expression Vectors 
Plasmids in this study were generated using Q5 High-Fidelity DNA polymerase (New 
England BioLabs, Ipswich, MA, U.S.A.), restriction enzymes (New England BioLabs, Ipswich, MA, 
U.S.A.), and Fast-linkTM DNA Ligase (Epicentre Technologies, Madison, WI, U.S.A.) according to 
the manufacturer’s instructions. For the construction of pJYW008 (Figure S1, Table S1), a 10.64 
kb DNA fragment was synthesized with the reverse primer JY017 and forward primer JY018 using 
pDCW173 (4)  as a template. After amplification, the PCR product was ligated via blunt-end 
ligation. The 9.96 kb (amplified using DCB151 and DCB152) and 10.62 kb (amplified using DCB152 
and DCB153) PCR amplified DNA fragments, using pDCW173 as a template, were synthesized for 
the construction of pDCYB037 and pDCYB038 (Table S1), respectively. These two linear DNA 
fragments were digested with SphI and ligated to construct pDCYB037 and pDCYB038, 
respectively.  The C. bescii CelA gene sequence (Cbes_1867; GenBank accession number Z86105) 
was codon optimized for expression in E. coli and cloned into a pET28b(+) vector using NcoI and 
XhoI sites (GenScript, Piscataway, NJ, U.S.A.). The sequence for a 6x histidine tag was placed at 
the C-terminus to facilitate protein purification. It was referred as pDCYB017 (Table S1). For the 
construction of pDCYB018 (Table S1), a 7.81 kb DNA fragment was synthesized with the reverse 
primer DCB068 and forward primer DCB069 using pDCYB017 as a template. After amplification, 
the PCR product was ligated via blunt-end ligation. The 7.78 kb (amplified using DCB155 and 
DCB157) and 7.11 kb (amplified using DCB157 and DCB256) PCR amplified DNA fragments, using 
pDCYB017 as a template, were synthesized for the construction of pDCYB075 and pDCYB076 
(Table S1), respectively. These two linear DNA fragments were digested with SphI and ligated to 
construct pDCYB075 and pDCYB076, respectively. 
To construct JWCB056, YBCB008, and YBCB009, plasmids pJYW024, pDCYB037, and 
pDCYB038 were electro-transformed into JWCB029 (ΔpyrFAΔldh::ISCbe4 Δcbe1ΔcelA) cells as 
previously described (2). Cultures, electro-pulsed with plasmid DNA (0.5 ~ 1.0 µg), were 
recovered in low osmolarity complex (LOC) growth medium (1) at 75°C. Recovery cultures were 
transferred to liquid LOD medium without uracil to allow selection of uracil prototrophs. Cultures 
were plated on solid LOD media to obtain isolated colonies, and total DNA was isolated from 
transformants. PCR amplification using primers (DCB008 and DCB010) outside the gene cassette 
on the plasmid was used to confirm the presence of the plasmid with the gene of interest intact. 
Primers used for plasmid constructions and confirmation are listed in Table S1. E. coli strain DH5a 
cells were transformed by electroporation in a 2-mm-gap cuvette at 2.5 V and transformants 
were selected for apramycin resistance. The sequences of all plasmids were confirmed by 
automatic sequencing (Genewiz, NJ, U.S.A.). All plasmids are available on request. 
Protein Expression in E. coli 
E. Coli BL21(DE3) was used for all experiments. Recombinant strains were grown in LB
broth supplemented with apramycin (50 μg/mL). Cultures were induced at 15°C with 0.25 mM 
IPTG when OD600=0.4. Cultures were centrifuged at 5,000xg for 10 min when OD600≥1.2. To 
recover intracellular protein, centrifuged cells were enzymatically lysed in Buffer A (50 mM Tris -
HCl, 40mM NaCl, 10mM Imidazole, pH 8.0) supplemented with lysozyme, protease inhibitors, 
and nuclease (Pierce, Waltham, MA, U.S.A.) at 4°C. Enzymatically lysed cells were subjected to 1 
minute of sonication in a water bath at 10 second intervals punctuated by 30 s on ice. Lysed cells 
were centrifuged at 10,000xg for 30 min. The lysate was recovered. 
Fermentation of C. bescii 
Each relevant strain of C. bescii was inoculated from frozen stocks into serum vials 
containing 20 mL of low osmolarity defined growth media (LOD) (1). Cultures were grown at 60°C 
for approximately 24 h. A 1% subculture into 200 mL of LOD from the 20 mL culture was then 
carried out. These cultures were grown between 18-24 h with occasional agitation if the cell 
growth was slow. All 200 mL of seed culture was then inoculated into 10-L fermentation vessels 
containing LOD media with 0.5% (w/v) cellobiose. Cultures were agitated at 50 RPM and sparged 
continuously with N2 at a flow rate of 0.5 liters per min while maintaining a pH of 6.8. A constant 
temperature of 65°C was maintained.  
The fermentation broth was separated from the cells by passing it through a polycap glass 
fiber filter (GE Healthcare Bio-Sciences, Marlborough, MA) before being concentrated using 
hollow fiber concentrators containing a 10 kDa cutoff membrane (GE Healthcare, Piscataway, NJ, 
U.S.A.). The concentrator was also used to buffer exchange the broth into Buffer A. 
Molecular simulations (Additional information) 
Each system was solvated in a box of explicit water molecules. For linkers in solution, 
approximate dimensions of the simulation boxes were 100 x 100 x 100 Å3; the total system size 
was approximately 100,000 atoms. For the three domains on cellulose, approximate dimensions 
of the simulation boxes were 230 x 125 x 90 Å3; the total system size was approximately 260,000 
atoms. 
For all systems, the CHARMM force field with CMAP was used to describe the proteins, (46) the 
carbohydrates were described with the C35 force field,(47, 48) and water was described with the 
TIP3P model.(49) All MD simulations utilized explicit solvent. The systems were built and 
minimized in CHARMM,(50) performing a stepwise protocol of minimization in which restraints 
are gradually released on protein, glycans, and cellulose surface. For the surface systems, all 
minimizations and simulations were performed with a harmonic restraint (force constant of 5 
kcal•mole-1•Å-2) on the glucopyranose ring atoms of the bottom cellulose layer as well as the first 
and last glucose ring of each cellulose chain (i.e. glucose residues 1 and 40). Following 
minimization, the system was heated from 100 K to 348 K over the course of 1 ns in the NVT 
ensemble. Systems were then density equilibrated for 1 ns in the NPT ensemble at a constant 
pressure of 1 atmosphere and constant temperature of 348 K (Nosé-Hoover barostat and 
thermostat); subsequent production runs were performed with constant volume and 
temperature (348 K) in NAMD.(51) All simulations were performed at a temperature of 348 K. 
This is higher than molecular simulations of enzymes are typically performed, but we target this 
temperature because this is the temperature that the assays for binding and hydrolytic activity 
of thermophilic CelA were performed.  The SHAKE algorithm was utilized to fix all bonded 
hydrogen distances.(52) The timestep was 2 fs. Nonbonded cutoff distance of 10 Å was utilized, 
with a switching distance of 9 Å, and a nonbonded pair list distance of 13 Å. The Particle Mesh 
Ewald method was used to describe the long-range electrostatics(53) with a sixth order b-spline, 
a Gaussian distribution with a width of 0.312 Å, and 1 Å grid spacing. The velocity Verlet multip le 
timestepping integration scheme was used evaluating the full nonbonded interactions every 
timestep, with full electrostatics interactions every 3 timesteps, and 6 timesteps between atom 
reassignments.  
 
Table S1: Caldicellulosiruptor bescii strains and plasmids used in this study 
Strains Description  Source 
JWCB029 ΔpyrFAΔldh::ISCbe4 Δcbe1 ΔcelA  (ura-/5-FOAR) (4) 
JWCB047 JWCB029 harboring pDCYB173 (4) 
JWCB056 JWCB029 harboring pJYW008 This study 
YBCB008 JWCB029 harboring pDCYB037  This study 
YBCB009 JWCB029 harboring pDCYB038 This study 
   
Plasmids   
pDCW173 C. bescii expression vector for full-length CelA  (ApramycinR) (4) 
pJYW008 C. bescii expression vector for C-terminus of CelA (CBM3-GH48) 
(ApramycinR) 
This study 
pDCYB037 C. bescii expression vector for N-terminus of CelA (GH9-CBM3) 
(ApramycinR) 
This study 
pDCYB038 C. bescii expression vector for N-terminus of CelA (GH9-CBM3-
CBM3) (ApramycinR) 
This study 
pDCYB017 E. coli expression vector for full-length CelA (ApramycinR) This study 
pDCYB018 E. coli expression vector for C-terminus of CelA (CBM3-GH48) 
(ApramycinR) 
This study 
pDCYB075 E. coli expression vector for N-terminus of CelA (GH9-CBM3-CBM3) 
(ApramycinR) 
This study 
pDCYB076 E. coli expression vector for N-terminus of CelA (GH9-CBM3) 
(ApramycinR) 
This study 
 
Table S2: List of primers used in this study. The underlined sequences indicate the recognition sites of the 
corresponding restriction enzymes.  
Name  Sequence (5’ → 3’) 
Restriction 
enzyme 
Description 
DCB008 AGAGTAGAGCGTGATGACATAGA  - To confirm transformants 
DCB010 ATCATCCCCTTTTGCTGATGGA - To confirm transformants 
JY017 AAACGAACCAGCCCTAACCTCTTGC  - To construct pJYW008 
JY018 GTA GCAGGCGGGCAGATAAAG - To construct pJYW008 
DCB151 GCATGCGAAAACTTGTATTTCCAGGGCCAT  SphI To construct pDCYB037 
DCB152 GCATGCTGTCGGTGTTGCTCCAGAAG SphI To construct 
pDCYB037/038 
DCB153 GCATGCTGTTGGTGTCGCTCCACTC  SphI To construct pDCYB038 
DCB068 GAAGGAGCCCATGGTATATCTC   To construct pDCYB018 
DCB069 GTTGCGGGTGGCCAAATCAAAG  To construct pDCYB018 
DCB155 GGATCCACCGCTCGGTTCCTGGCC  BamHI To construct pDCYB075 
DCB157 GGATCCGAAAACTTGTATTTCCAGGGCCTCG  BamHI To construct 
pDCYB075/076 
DCB206 GGATCCACCGCTGGTACCCGGTTCTTC BamHI To construct pDCYB076 
 
 
Table S3: Actual protein concentrations with percent difference between the control and the unbound fraction  
found in Figure 6. 
 CelA expressed in C. bescii CelA expressed in E. coli 
Control 0.123 mg/ml 0.130 mg/ml 
Unbound to Avicel 0.033 mg/ml 0.013 mg/ml 
% Protein unbound to Avicel 26% 10% 
Control 0.103 mg/ml 0.142 mg/ml 
Unbound to Lignin 0.089 mg/ml 0.065 mg/ml 
% protein unbound to lignin 86% 45% 
 
 
 
 
 
 
Figure S1: Plasmid maps of Caldicellulosiruptor bescii expression vectors for full-length (FL; GH9-CBM3c-CBM3b-
CBM3b-GH48) (A), C-terminal part of CelA (CT; CBM3b-GH48) (B), N-terminal part of CelA (NT1; GH9-CBM3c-CBM3b) 
(C), and N-terminal part of CelA (NT2; GH9-CBM3c) (D) expression.  Various CelA derivatives were expressed under 
the control of the regulatory region of the C. bescii S-layer protein. The expression vectors contain a signal peptide 
sequence derived from CelA, a C-terminal 6X His-tag, a Rho independent terminator, the pyrF (from C. thermocellum) 
cassette for selection, and pBAS2 sequences for replication in C. bescii. The apramycin resistant gene cassette (AprR), 
pSC101 low copy replication origin in E. coli, and repA, a plasmid-encoded gene required for pSC101 replication are 
indicated.  
 Figure S2: Amino acid sequences of CelA and its truncation mutants; (A) Full -length (FL), (B) C-terminal part of CelA (CT), (C) 
N-terminal part of CelA (NT1), and (D) N-terminal part of CelA (NT2). The color-coded letters denote domain organization; 
letters in brown (CelA signal peptide), purple (GH9 domain), red (linker sequences),  green (CBM3c domain), blue (CBM3b 
domain), black (GH48 domain). 
 
 
MKRYRRIIAMVVTFIFILGVVYGVKPWQEVRAGSFNYGEALQKAIMFYEFQMSGKLPNWVRNNWRGDSALKDGQDNGLDLTGGWFDAGDHVKFNLPMSYTGTMLSWAVYEYK
DAFVKSGQLEHILNQIEWVNDYFVKCHPSKYVYYYQVGDGSKDHAWWGPAEVMQMERPSFKVTQSSPGSTVVAETAASLAAASIVLKDRNPTKAATYLQHAKELYEFAEVTKSDA
GYTAANGYYNSWSGFYDELSWAAVWLYLATNDSTYLTKAESYVQNWPKISGSNTIDYKWAHCWDDVHNGAALLLAKITGKDIYKQIIESHLDYWTTGYNGERIKYTPKGLAWLDQ
WGSLRYATTTAFLAFVYSDWVGCPSTKKEIYRKFGESQIDYALGSAGRSFVVGFGTNPPKRPHHRTAHSSWADSQSIPSYHRHTLYGALVGGPGSDDSYTDDISNYVNNEVACDYN
AGFVGALAKMYQLYGGNPIPDFKAIETPTNDEFFVEAGINASGTNFIEIKAIVNNQSGWPARATDKLKFRYFVDLSELIKAGYSPN QLTLSTNYNQGAKVSGPYVWDASKNIYYILVDF
TGTLIYPGGQDKYKKEVQFRIAAPQNVQWDNSNDYSFQDIKGVSSGSVVKTKYIPLYDGDVKVWGEEPGTSGA TPTPTATATPTPTPTVTPTPTPTPTSTATPTPTPTPTVTPTPTPT
PTATPTATPTPTSTPSSTPVAGGQIKVLYANKETNSTTNTIRPWLKVVNTGSSSIDLSRVTIRYWYTVDGDKAQSAISDWAQIGASNVTFKFVKLSSSVSGADYYLEIGFKSGAGQLQA
GKDTGEIQIRFNKSDWSNYNQGNDWSWMQSMTNYGENVKVTAYIDGVLVWGQEPSGA TPTPTATPAPTVTPTPTPTPTSTPTATPTATPTPTPTPSSTPVAGGQIKVLYANKETN
STTNTIRPWLKVVNTGSSSIDLSRVTIRYWYTVDGDKAQSAISDWAQIGASNVTFKFVKLSSSVSGADYYLEIGFKSGAGQLQAGKDTGEIQIRFNKSDWSNYNQGNDWSWMQSM
TNYGENVKVTAYIDGVLVWGQEPSGATPTPTATPAPTVTPTPTPAPTPTPTPTPTATPTPTPTPTPTATPTVTATPTPTPSSTPSVLGEYGQRFMWLWNKIHDPANGYFNQDGIPYH
SVETLICEAPDYGHLTTSEAFSYYVWLEAVYGKLTGDWSKFKTAWDTLEKYMIPSAEDQPMRSYDPNKPATYAGEWETPDKYPSPLEFNVPVGKDPLHNELVSTYGSTLMYGMHW
LMDVDNWYGYGKRGDGVSRASFINTFQRGPEESVWETVPHPSWEEFKWGGPNGFLDLFIKDQNYSKQWRYTDAPDADARAIQATYWAKVWAKEQGKFNEISSYVAKAAKMG
DYLRYAMFDKYFKPLGCQDKNAAGGTGYDSAHYLLSWYYAWGGALDGAWSWKIGSSHVHFGYQNPMAAWALANDSDMKPKSPNGASDWAKSLKRQ IEFYRWLQSAEGAIA
GGATNSWNGRYEKYPAGTATFYGMAYEPNPVYHDPGSNTWFGFQAWSMQRVAEYYYVTGDKDAGALLEKWVSWVKSVVKLNSDGTFAIPSTLDWSGQPDTWNGAYTGNSN
LHVKVVDYGTDLGITASLANALLYYSAGTKKYGVFDEGAKNLAKELLDRMWKLYRDEKGLSAPEKRADYKRFFEQEVYIPAGWIGKMPNGDVIKSGVKFIDIRSKYKQDPDWPKLEA
AYKSGQAPEFRYHRFWAQCDIAIANATYEILFGNQ 
A) Full-length (FL; GH9-CBM3c-CBM3b-CBM3b-GH48)  
MKRYRRIIAMVVTFIFILGVVYGVKPWQEVRAGSFVAGGQIKVLYANKETNSTTNTIRPWLKVVNTGSSSIDLSRVTIRYWYTVDGDKAQSAISDWAQIGASNVTFKFVKLSSSVSGA
DYYLEIGFKSGAGQLQAGKDTGEIQIRFNKSDWSNYNQGNDWSWMQSMTNYGENVKVTAYIDGVLVWGQEPSGA TPTPTATPAPTVTPTPTPAPTPTPTPTPTATPTPTPTPTPT
ATPTVTATPTPTPSSTPSVLGEYGQRFMWLWNKIHDPANGYFNQDGIPYHSVETLICEAPDYGHLTTSEAFSYYVWLEAVYGKLTGDWSKFKTAWDTLEKYMIPSAEDQPMRSYDP
NKPATYAGEWETPDKYPSPLEFNVPVGKDPLHNELVSTYGSTLMYGMHWLMDVDNWYGYGKRGDGVSRASFINTFQRGPEESVWETVPHPSWEEFKWGGPNGFLDLFIKDQNY
SKQWRYTDAPDADARAIQATYWAKVWAKEQGKFNEISSYVAKAAKMGDYLRYAMFDKYFKPLGCQDKNAAGGTGYDSAHYLLSWY YAWGGALDGAWSWKIGSSHVHFGYQ
NPMAAWALANDSDMKPKSPNGASDWAKSLKRQIEFYRWLQSAEGAIAGGATNSWNGRYEKYPAGTATFYGMAYEPNPVYHDPGSNTWFGFQAWSMQRVAEYYYVTGDKDA
GALLEKWVSWVKSVVKLNSDGTFAIPSTLDWSGQPDTWNGAYTGNSNLHVKVVDYGTDLGITASLANALLYYSAGTKKYGVFDEGAKNLAKELLDRMWKLYRDEKGLSAPEKRAD
YKRFFEQEVYIPAGWIGKMPNGDVIKSGVKFIDIRSKYKQDPDWPKLEAAYKSGQAPEFRYHRFWAQCDIAIANATYEILFGNQ  
B) C-terminal truncation mutant (CT; CBM3b-GH48) 
MKRYRRIIAMVVTFIFILGVVYGVKPWQEVRAGSFNYGEALQKAIMFYEFQMSGKLPNWVRNNWRGDSALKDGQDNGLDLTGGWFDAGDHVKFNLPMSYTGTMLSWAVYEYK
DAFVKSGQLEHILNQIEWVNDYFVKCHPSKYVYYYQVGDGSKDHAWWGPAEVMQMERPSFKVTQSSPGSTVVAETAASLAAASIVLKDRNPTKAATYLQHAKELYEFAEVTKSDA
GYTAANGYYNSWSGFYDELSWAAVWLYLATNDSTYLTKAESYVQNWPKISGSNTIDYKWAHCWDDVHNGAALLLAKITGKDIYKQIIESHLDYWTTGYNGERIKYTPKGLAWLDQ
WGSLRYATTTAFLAFVYSDWVGCPSTKKEIYRKFGESQ IDYALGSAGRSFVVGFGTNPPKRPHHRTAHSSWADSQSIPSYHRHTLYGALVGGPGSDDSYTDDISNYVNNEVACDYNA
GFVGALAKMYQLYGGNPIPDFKAIETPTNDEFFVEAGINASGTNFIEIKAIVNNQSGWPARATDKLKFRYFVDLSELIKAGYSPNQLTLSTNYNQGAKVSGPYVWDASKNIYYILVDFT
GTLIYPGGQDKYKKEVQFRIAAPQNVQWDNSNDYSFQDIKGVSSGSVVKTKYIPLYDG DVKVWGEEPGTSGA 
D) N-terminal truncation mutant (NT2; GH9-CBM3c) 
MKRYRRIIAMVVTFIFILGVVYGVKPWQEVRAGSFNYGEALQKAIMFYEFQMSGKLPNWVRNNWRGDSALKDGQDNGLDLTGGWFDAGDHVKFNLPMSYTGTMLSWAVYEYK
DAFVKSGQLEHILNQIEWVNDYFVKCHPSKYVYYYQVGDGSKDHAWWGPAEVMQMERPSFKVTQSSPGSTVVAETAASLAAASIVLKDRNPTKAATYLQHAKELYEFAEVTKSDA
GYTAANGYYNSWSGFYDELSWAAVWLYLATNDSTYLTKAESYVQNWPKISGSNTIDYKWAHCWDDVHNGAALLLAKITGKDIYKQIIESHLDYWTTGYNGERIKYTPKGLAWLDQ
WGSLRYATTTAFLAFVYSDWVGCPSTKKEIYRKFGESQIDYALGSAGRSFVVGFGTNPPKRPHHRTAHSSWADSQSIPSYHRHTLYGALVGGPGSDDSYTDDISNYVNNEVACDYNA
GFVGALAKMYQLYGGNPIPDFKAIETPTNDEFFVEAGINASGTNFIEIKAIVNNQSGWPARATDKLKFRYFVDLSELIKAGYSPN QLTLSTNYNQGAKVSGPYVWDASKNIYYILVDFT
GTLIYPGGQDKYKKEVQFRIAAPQNVQWDNSNDYSFQDIKGVSSGSVVKTKYIPLYDGDVKVWGEEPGTSGA TPTPTATATPTPTPTVTPTPTPTPTSTATPTPTPTPTVTPTPTPTPT
ATPTATPTPTSTPSSTPVAGGQIKVLYANKETNSTTNTIRPWLKVVNTGSSSIDLSRVTIRYWYTVDGDKAQSAISDWAQIGASNVTFKFVKLSSSVSGADYY LEIGFKSGAGQLQAGK
DTGEIQIRFNKSDWSNYNQGNDWSWMQSMTNYGENVKVTAYIDGVLVWGQEPSGA 
C) N-terminal truncation mutant (NT1; GH9-CBM3c-CBM3b) 
 Figure S3: SDS-PAGE and glycoprotein staining demonstrates heavy glycosylation of the linker regions within C. 
bescii CelA. Following SDS-PAGE, a periodic acid Schiff glycoprotein stain was applied that preferentially stained the 
glycosylated proteins magenta. Following glycoprotein staining, a standard colloidal blue stain revealed non -
glycosylated proteins. C. bescii expressed CelA, CT, and NT1 are all glycosylated as seen by the magenta color and 
higher MW compared to E. coli expressed proteins. C. bescii and E. coli expressed NT2 ran at the same 
electrophoretic mobility and neither was specifically  stained (See Figure 2 in the main text). 
 
 
 Figure S4: MALDI-TOF-MS spectrum of glycomics analysis of CelA (GH9-CBM3c-CBM3b-CBM3b-GH48) sample by ß-
elimination. The presence of Hex1, Hex2, Hex3, and Hex4 is shown. 
 
 
 
Figure S5: O-linked glycans in CelA (GH9-CBM3c-CBM3b-CBM3b-GH48) HPAEC chromatogram of monosaccharides 
from CelA (GH9-CBM3c-CBM3b-CBM3b-GH48) O-linked glycans separated by CarboPacPA 20 column shows presence 
of, galactose (Gal), glucose (Glc), and mannose (Man). Although Glc was detected, we could not determine if this 
residue is part of the O-glycans structures or simply a contaminant as often as the case.  
 
  
Figure S6: Linkage analysis by GC-MS of partially methylated alditol acetates of O-glycans from CelA (GH9-CBM3c-
CBM3b-CBM3b-GH48) 
 
 
 
 
Figure S7: MALDI-TOF-MS spectrum of glycomics analysis of NT1 (GH9-CBM3c-CBM3b) sample by ß-elimination. 
The presence of Hex1, Hex2, and Hex3 is shown. 
 
 
 
Figure S8: O-linked glycans in NT1 (GH9-CBM3c-CBM3b) HPAEC chromatogram of monosaccharides from NT1 (GH9-
CBM3c-CBM3b) O-linked glycans separated by CarboPacPA 20 column shows presence of; galactose (Gal), glucose 
(Glc), and mannose (Man). Although Glc was detected, we could not determine if this residue is part of the O -glycans 
structures or simply a contaminant as often is the case. 
 
 Figure S9: MALDI-TOF-MS Spectrum of glycomics analysis of CT (CBM3b-GH48) sample by ß-elimination. The 
presence of Hex1, Hex2, and Hex3 is shown. 
 
 
Figure S10:  O-linked glycans in CT (CBM3b-GH48) HPAEC chromatogram of monosaccharides from CT (CBM3b-GH48) 
O-linked glycans separated by CarboPacPA 20 column shows presence of, galactose (Gal), glucose (Glc), and 
mannose (Man). Although Glc was detected, we could not determine if this residue is part of the O -glycans structures 
or simply a contaminant as often as the case. 
 
  
Figure S11: Predicted thermolysin cleavage sites in linker between CBM3c and CBM3b. The ExPASY tool 
PeptideCutter predicts sites for CelA linker cleavage based on the canonical recognition sequence of thermolysin. 
Within the CelA linker sequences, threonine-alanine and threonine-valine motifs are common; thermolysin 
preferentially cleaves the scissile bond N-terminal to a valine or alanine.  
 
 
Figure S12: Cleavage with a promiscuous, thermostable protease highlights protective role of glycosylation. CelA 
expressed in C. bescii and E. coli were digested at 70°C by thermolysin from Bacillus thermoproteolyticus for four 
hours. Thermolysin scissile bonds are present throughout the amino acid sequence of CelA, including in the linker 
peptides (Figure S11). C. bescii CelA is robust to thermolysin degradation. Even after four hours, most of the protein 
remains intact. However, E. coli CelA is fully degraded in only thirty minutes. Glycosylation distributed throughout 
the linker peptides provides a strong protective barrier against thermolysin cleavage. (X) Protein subjected to heat 
only, no thermolysin, for 4 hours.  
 
 Figure S13: Setup configurations for molecular dynamics (MD) simulations. Linker 3 (see Figure 2A in main text) in 
solution: A) non-glycosylated, B) with “base case” glycosylation, and C) “doubly glycosylated.” Linker 3 with adjacent 
CBM3b domains on the hydrophobic surface of cellulose: D) non-glycosylated, E) with “base case” glycosylation, F) 
with “base case” glycosylation started with linker unbound, and G) “doubly glycosylated.” 
 
 Figure S14: Effect of glycosylation on spatial fluctuations from MD simulations. A) System set-up with “base case” 
glycosylation; B) Root mean squared fluctuations (RMSF) for the three levels of glycosylation studied. C) The residues 
on each CBM3b domain within 4 Å of any linker glycan are shown in gray “sticks” every 2 ns over the course of the 
340 ns simulation for C) base case glycosylation and D) doubly glycosylated system. The top level of the cellulose 
surface is shown as green spheres, the CBM3b and linker domains are shown as a transparent surface.  
 
  
Figure S15: Effect of glycosylation on linker extension from MD simulations. As measured by both radius of 
gyration (left) and end-to-end length (right), addition of linker glycans extends the linker domain, both with 
isolated linker in solution and with adjacent CBM3b domains on the surface of cellulose  
 
 
Figure S16: Effect of glycosylation on solvent accessible surface area (SASA) from MD simulations. Both with 
isolated linkers in solution and for linkers attached to CBM3b domains on the surface of cellulose, SASA is reduced 
by the addition of linkers. This is despite the extending effect of the linker glycans (Figure S15). This is calculated 
with a 1.4 Å probe size, as appropriate for a water molecule.  
 
 
  
 
Figure S17: SDS gels of C. bescii (a) and E. coli (b) CelA after incubation with Avicel and lignin. 
At first glance, there appears to be a difference in the affinity of CelA toward Avicel and lignin when 
comparing expression in C. bescii and E. coli.  In Figure S16a, there is a CelA protein band in the lane of the unbound 
supernatant for Avicel as well as in the unbound supernatant to lignin, whereas in the case with CelA expressed in 
E. coli the CelA protein band appears to be primarily in the bound fraction of Avicel but it less obvious in the case of 
lignin. Therefore, densitometry was performed on these gels to measure and quantify the amount of protein lost to 
both Avicel and lignin utilizing ImageJ gel analysis (developed at the National Institutes of Health 
(http://rsb.info.nih.gov/ij/docs/menues/analyze.html#gels)).  Densitometry was used  in conjunction with ImageJ to 
quantify the amount of protein and the percent difference between the control and unbound fractions (5, 6).  
A calibration curve between pixel density and total protein concentration was developed ( Figure S18) for 
CelA expressed in both C. bescii and E. coli using the purified enzymes at varying concentration from 0.02 mg/ml to 
0.14 mg/ml.  From this standard curve, protein concentrations were calculated for the control and unbound fraction.  
Protein quantification was not performed on the bound fraction due to the increased background within the lane 
caused by the Avicel and lignin residues.  
 
 
 
Figure S18:  Calibration curves for CelA expressed in C. bescii (red) and CelA expressed in E. coli (blue) for 
quantification of protein concentration.   These curves were developed using gel analysis software in Image J and 
used to measure the amount of protein in a given band (http://rsb.info.nih.gov/ij/docs/menues/analyze.html#gels).  
 
 
 
 
 
Figure S19:  Location of hydrophobic patches in CelA linkers. Hydrophobic patches for CelA linkers calculated using 
the structures from four different CelA conformations are shown in blue as VDW spheres scaled by scores.  
 
 
 Linker 1 Linker 2 Linker 3 Linker 4 
Total 
linkers 
C1 5.76 7.84 40.96 7.84 62.4 
C2 16 5.76 5.76 16 43.52 
C3 12.96 19.36 7.84 4 44.16 
C4 4 10.24 36 27.04 77.28 
 
 
Figure S20:  Hydrophobic patch score of CelA linkers.  The highest hydrophobic patch score for each linker was 
calculated using the structures from four different CelA  conformations.  The total score is the sum of the highest 
scores for each linker. In a previous study, we reported that proteins with scores above 35 were susceptible to non 
productive binding to lignin. 
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